Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Streptococcus mutans glucosyltransferases (GTFs) and surface adhesins are primary virulence factors responsible for the initiation and progression of dental caries [1]. GTFs, specifically GtfB, GtfC, and GtfD, are enzymes that catalyze the conversion of dietary sucrose into water-insoluble and soluble glucans, which constitute the essential structural scaffold of the dental plaque matrix [2]. Surface adhesins, most notably the Antigen I/II family (also known as SpaP, PAc, or P1), facilitate the initial attachment of S. mutans to the salivary pellicle coating the tooth enamel [3]. Together, these proteins enable the formation of a robust, acidogenic biofilm that protects the bacteria from environmental stress and concentrates organic acids, leading to the demineralization of tooth enamel [4]. Therapeutic targeting of these molecules aims to prevent cavities by inhibiting biofilm integrity and bacterial colonization rather than relying on broad-spectrum bactericidal agents [5]. Current pharmacological approaches include the use of fluoride to inhibit enzyme metabolism, chlorhexidine for broad biofilm disruption, and various natural polyphenols that specifically interfere with GTF activity and adhesin binding [6]. [1] https://pubmed.ncbi.nlm.nih.gov/21242687/ [2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055735/ [3] https://pubmed.ncbi.nlm.nih.gov/20633131/ [4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741677/ [5] https://pubmed.ncbi.nlm.nih.gov/21775778/ [6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133681/
Inhibition of glucosyltransferase enzymatic activity to prevent the synthesis of extracellular glucans and disruption of adhesin-mediated bacterial attachment to the salivary pellicle on tooth surfaces.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus mutans glucosyltransferase and surface adhesin (GTF/Adhesin).